RE:RE:RE:RE:$100 million...LaserStock29 wrote: The Deal I assume this is the one... honestly whatever gets our PPS to $4 and Nasdaq...
Under the terms of the agreement, JT will make an upfront payment to OPKO of $6 million with another $6 million payment to be made upon initiation of OPKO’s planned phase 2 study of RAYALDEE in U.S. dialysis patients. In addition, OPKO will be eligible to receive up to an additional $31 million in development and regulatory milestones and $75 million in sales based milestones. JT will also pay OPKO tiered, double digit royalties on net product sales. JT will be responsible for all regulatory approvals and commercial activities pertaining to RAYALDEE in Japan.
quote=skier59]We don't need $100 million upfront. Look at how that deal was done with Frost and that Pharma company in Japan. Small up front payment of $5-10 million is all we need right now, and then once certain milestones are achieved such as Phase 2 approval, which is really a slam dunk for us, there would be another injection of cash and then an upfront payment for Licensing on commercialization. The deal could be announced as a $100 million deal and the market will jump in very quickly. It will demonstrate a conviction from a very well respected businessman in the USA. Not 1 new share issued in the market, Johnny BJ loses his job here, and goes and works on another board with a new avatar. Peace and Love :)
Bada Bing, Bada Bang, Kaboom....$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
[/quote]
Agree. To seek a up-listed to NASDAQ of over $4.00 + is another better option, all RW needs to do is just forget about the miserable begging for a low valued useless PP. RW is not stupid, but he seems to be too obsessed with the former rapers to do another round cheap PP , and just wants to negotiate for a better deal this time. We long shareholders have the obligations to remind him, say no to cheap PP, we have much better solutions.